Pharmacology Watch – April 1, 2016
April 1, 2016
View Issues
-
Long-term Aspirin Use Reduces Risk of Cancer
Regular aspirin use could prevent 33 colorectal cancers per 100,000 person years among those who had not undergone lower endoscopy and 18 colorectal cancers per 100,000 person years in those who had undergone screening.
-
More Doubt About ‘Female Viagra’
Flibanserin, on average, resulted in a one-half additional satisfying sexual event per month while significantly raising the risk of dizziness, somnolence, nausea, and fatigue.
-
Treating Gout with Oral Steroids
New research indicates prednisolone is an effective and safe first-line option for the treatment of acute gout.
-
A Secondary Prevention Against Cardiovascular Events?
A recent study found that in patients without diabetes but with insulin resistance along with a history of ischemic stroke or TIA, pioglitazone reduced the risk of stroke or myocardial infarction compared to placebo.
-
Report: Prescriptions for Hydrocodone-containing Combination Drugs Drop
The switch of hydrocodone-containing combination drugs from Schedule III to the more restrictive Schedule II in October 2014 significantly reduced the number of prescriptions filled for these drugs, according to a new study.
-
FDA Actions
In this section: Senate confirms new FDA commissioner, and the FDA approves brivaracetam as adjunctive treatment for partial onset seizures.